{"success":true,"data":{"pressRelease":{"id":"135167","rtpr_id":"nGNX6YNM5Z","ticker":"CYCU","exchange":"NASDAQ","all_tickers":["CYCU","CYCUW"],"title":"Cycurion Announces Approximately $800,000 in Annual Contract Spend, Accelerating Commercial Expansion","author":"Globe Newswire","published_at":"2026-09-03T12:30:01.206Z","article_body":"MCLEAN, Va., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU)\n(“Cycurion” or the “Company”), a trusted leader in IT cybersecurity\nand AI-driven solutions, today announced several engagements totaling\napproximately $800,000 in annual contract spend. The work includes a\npharmaceutical-industry engagement to support an AI Center of Excellence, a\nnew award with the National Association of County and City Health Officials\n(NACCHO), and additional commercial and public-health engagements. This is the\nfirst public announcement of these awards.\n\nThis is the commercial expansion Cycurion told the market it was going after.\nThe Company is building commercial healthcare and life-sciences work as a\nprimary growth market, while continuing to run its government and\npublic-safety franchise. Scope across the engagements includes business\ncontinuity and disaster recovery, technology and cybersecurity assessments,\nprogram management, organizational change management, and AI operating\ncapability.\n\nThe announcement reflects the Company’s deliberate strategy — as\npreviously communicated to the market — to accelerate expansion into\ncommercial healthcare, life sciences, and other non-government sectors where\ndemand for resilient IT, cybersecurity, and AI-enabled operating capability\ncontinues to grow.\n\n“These wins are exactly the kind of commercial traction we told the market\nwe were going after,” said L. Kevin Kelly, Chairman and Chief Executive\nOfficer of Cycurion. “A pharmaceutical organization has engaged us to\nsupport its AI Center of Excellence. NACCHO has awarded new work. Customers\nare not paying for slogans. They are paying for resilience, cybersecurity,\nprogram delivery, and AI that has to run in a real operating environment. Each\nof these engagements puts us inside an organization that will need more of\nwhat we do. We are not dabbling in commercial. We are building it.”\n\nWhat the Work Covers\n\nAcross the commercial and NACCHO-related engagements, Cycurion is supporting\nclients with:\n* Business continuity and disaster recovery planning and execution\n* Technology and cybersecurity assessments\n* Program management for complex technology initiatives\n* Organizational change management\n* Support for an AI Center of Excellence for a pharmaceutical organization\nThe pharmaceutical AI Center of Excellence engagement is a commercial\nlife-sciences win the Company has been building toward. The NACCHO award is\nbeing announced for the first time and deepens Cycurion’s existing\nrelationship with the association, including its standing as a Diamond\nAffiliate Partner. Additional commercial and public-health work is included in\nthe approximately $800,000 annual contract-spend total.\n\nWhy It Matters\n\nThe number is approximately $800,000 in annual contract spend. The signal is\nthe market. These engagements convert a stated commercial strategy into work\nin pharmaceutical, healthcare, and public health, and they put Cycurion inside\naccounts that can grow. Government and public safety remain core. Commercial\nis a market Cycurion is going after.\n\nThe Company will continue to pursue additional commercial and non-government\nopportunities that fit its capabilities in cybersecurity, managed IT, program\ndelivery, and AI-enabled transformation.\n\nAbout Cycurion, Inc. \n\nBased in McLean, Virginia, Cycurion (Nasdaq: CYCU) is a forward-thinking\nprovider of IT cybersecurity solutions and AI, committed to delivering secure,\nreliable, and innovative services to clients worldwide. Specializing in\ncybersecurity, program management, and business continuity, Cycurion harnesses\nits AI-enhanced ARx platform and expert team to empower clients and safeguard\ntheir operations. Along with its subsidiaries, Axxum Technologies LLC,\nCloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves\ngovernment, healthcare, and corporate clients committed to securing the\ndigital future. For more information, visit www.cycurion.com. \n\nForward-Looking Statements \n\nThis press release contains forward-looking statements as defined in the\nPrivate Securities Litigation Reform Act of 1995, including, but not limited\nto, statements relating to the operations and prospective growth of\nCycurion’s business.\n\nCertain statements in this press release that are not historical facts are\nforward-looking statements within the meaning of Section 27A of the Securities\nExchange Act of 1934, as amended. Any statements contained in this press\nrelease that are not statements of historical fact may be deemed\nforward-looking statements. Such statements include, but are not limited to,\nstatements regarding the approximately $800,000 in aggregate annual contract\nspend associated with the new awards; the scope, timing and duration of the\nservices to be provided under those awards; the Company’s ability to perform\nunder the new contracts and to realize their anticipated benefits; the\ndevelopment of an AI Center of Excellence for a pharmaceutical organization;\nthe expansion of the Company’s commercial healthcare, life sciences and\nother non-government business; the Company’s expectation that these\nengagements will lead to additional work with these clients; the deepening of\nthe Company’s relationship with NACCHO and its member organizations; the\nCompany’s ability to identify and win additional commercial and\nnon-government opportunities; the continued execution on the Company’s\nbacklog; and other statements that are not historical facts. Words such as\n“continue,” “will,” “may,” “could,” “should,”\n“expect,” “expected,” “plans,” “intend,” “anticipate,”\n“believe,” “estimate,” “predict,” “potential,” and similar\nexpressions are intended to identify such forward-looking statements. All\nforward-looking statements involve significant risks and uncertainties that\ncould cause actual results to differ materially from those expressed or\nimplied in the forward-looking statements, many of which are generally outside\nthe control of Cycurion and are difficult to predict. Examples of such risks\nand uncertainties include, but are not limited to, risks related to customer\nperformance and satisfaction, contract modifications, delays or terminations,\nand the Company’s ability to fulfill contractual obligations; the outcomes\nof the Company’s investigations, any potential legal proceedings, or the\nfuture performance of the Company’s stock. Additional factors that could\ncause actual results to differ materially from those expressed or implied in\nthe forward-looking statements can be found in the most recent annual report\non Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K\nfiled by Cycurion with the U.S. Securities and Exchange Commission. Cycurion\nanticipates that subsequent events and developments may cause its plans,\nintentions, and expectations to change. Cycurion assumes no obligation, and it\nspecifically disclaims any intention or obligation, to update any\nforward-looking statements, whether as a result of new information, future\nevents, or otherwise, except as expressly required by law. Forward-looking\nstatements speak only as of the date they are made and should not be relied\nupon as representing Cycurion’s plans and expectations as of any subsequent\ndate.\n\nCycurion Investor Relations: \n(888) 341-6680 \ninvestors@cycurion.com \n\nCycurion Media Relations: \n(888) 341-6680 \nmedia@cycurion.com\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX6YNM5Z","title":"Cycurion Announces Approximately $800,000 in Annual Contract Spend, Accelerating Commercial Expansion","author":"Globe Newswire","ticker":"CYCU","created":"2026-09-03T12:30:01.206Z","tickers":["CYCU","CYCUW"],"exchange":"NASDAQ","article_body":"MCLEAN, Va., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU)\n(“Cycurion” or the “Company”), a trusted leader in IT cybersecurity\nand AI-driven solutions, today announced several engagements totaling\napproximately $800,000 in annual contract spend. The work includes a\npharmaceutical-industry engagement to support an AI Center of Excellence, a\nnew award with the National Association of County and City Health Officials\n(NACCHO), and additional commercial and public-health engagements. This is the\nfirst public announcement of these awards.\n\nThis is the commercial expansion Cycurion told the market it was going after.\nThe Company is building commercial healthcare and life-sciences work as a\nprimary growth market, while continuing to run its government and\npublic-safety franchise. Scope across the engagements includes business\ncontinuity and disaster recovery, technology and cybersecurity assessments,\nprogram management, organizational change management, and AI operating\ncapability.\n\nThe announcement reflects the Company’s deliberate strategy — as\npreviously communicated to the market — to accelerate expansion into\ncommercial healthcare, life sciences, and other non-government sectors where\ndemand for resilient IT, cybersecurity, and AI-enabled operating capability\ncontinues to grow.\n\n“These wins are exactly the kind of commercial traction we told the market\nwe were going after,” said L. Kevin Kelly, Chairman and Chief Executive\nOfficer of Cycurion. “A pharmaceutical organization has engaged us to\nsupport its AI Center of Excellence. NACCHO has awarded new work. Customers\nare not paying for slogans. They are paying for resilience, cybersecurity,\nprogram delivery, and AI that has to run in a real operating environment. Each\nof these engagements puts us inside an organization that will need more of\nwhat we do. We are not dabbling in commercial. We are building it.”\n\nWhat the Work Covers\n\nAcross the commercial and NACCHO-related engagements, Cycurion is supporting\nclients with:\n* Business continuity and disaster recovery planning and execution\n* Technology and cybersecurity assessments\n* Program management for complex technology initiatives\n* Organizational change management\n* Support for an AI Center of Excellence for a pharmaceutical organization\nThe pharmaceutical AI Center of Excellence engagement is a commercial\nlife-sciences win the Company has been building toward. The NACCHO award is\nbeing announced for the first time and deepens Cycurion’s existing\nrelationship with the association, including its standing as a Diamond\nAffiliate Partner. Additional commercial and public-health work is included in\nthe approximately $800,000 annual contract-spend total.\n\nWhy It Matters\n\nThe number is approximately $800,000 in annual contract spend. The signal is\nthe market. These engagements convert a stated commercial strategy into work\nin pharmaceutical, healthcare, and public health, and they put Cycurion inside\naccounts that can grow. Government and public safety remain core. Commercial\nis a market Cycurion is going after.\n\nThe Company will continue to pursue additional commercial and non-government\nopportunities that fit its capabilities in cybersecurity, managed IT, program\ndelivery, and AI-enabled transformation.\n\nAbout Cycurion, Inc. \n\nBased in McLean, Virginia, Cycurion (Nasdaq: CYCU) is a forward-thinking\nprovider of IT cybersecurity solutions and AI, committed to delivering secure,\nreliable, and innovative services to clients worldwide. Specializing in\ncybersecurity, program management, and business continuity, Cycurion harnesses\nits AI-enhanced ARx platform and expert team to empower clients and safeguard\ntheir operations. Along with its subsidiaries, Axxum Technologies LLC,\nCloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves\ngovernment, healthcare, and corporate clients committed to securing the\ndigital future. For more information, visit www.cycurion.com. \n\nForward-Looking Statements \n\nThis press release contains forward-looking statements as defined in the\nPrivate Securities Litigation Reform Act of 1995, including, but not limited\nto, statements relating to the operations and prospective growth of\nCycurion’s business.\n\nCertain statements in this press release that are not historical facts are\nforward-looking statements within the meaning of Section 27A of the Securities\nExchange Act of 1934, as amended. Any statements contained in this press\nrelease that are not statements of historical fact may be deemed\nforward-looking statements. Such statements include, but are not limited to,\nstatements regarding the approximately $800,000 in aggregate annual contract\nspend associated with the new awards; the scope, timing and duration of the\nservices to be provided under those awards; the Company’s ability to perform\nunder the new contracts and to realize their anticipated benefits; the\ndevelopment of an AI Center of Excellence for a pharmaceutical organization;\nthe expansion of the Company’s commercial healthcare, life sciences and\nother non-government business; the Company’s expectation that these\nengagements will lead to additional work with these clients; the deepening of\nthe Company’s relationship with NACCHO and its member organizations; the\nCompany’s ability to identify and win additional commercial and\nnon-government opportunities; the continued execution on the Company’s\nbacklog; and other statements that are not historical facts. Words such as\n“continue,” “will,” “may,” “could,” “should,”\n“expect,” “expected,” “plans,” “intend,” “anticipate,”\n“believe,” “estimate,” “predict,” “potential,” and similar\nexpressions are intended to identify such forward-looking statements. All\nforward-looking statements involve significant risks and uncertainties that\ncould cause actual results to differ materially from those expressed or\nimplied in the forward-looking statements, many of which are generally outside\nthe control of Cycurion and are difficult to predict. Examples of such risks\nand uncertainties include, but are not limited to, risks related to customer\nperformance and satisfaction, contract modifications, delays or terminations,\nand the Company’s ability to fulfill contractual obligations; the outcomes\nof the Company’s investigations, any potential legal proceedings, or the\nfuture performance of the Company’s stock. Additional factors that could\ncause actual results to differ materially from those expressed or implied in\nthe forward-looking statements can be found in the most recent annual report\non Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K\nfiled by Cycurion with the U.S. Securities and Exchange Commission. Cycurion\nanticipates that subsequent events and developments may cause its plans,\nintentions, and expectations to change. Cycurion assumes no obligation, and it\nspecifically disclaims any intention or obligation, to update any\nforward-looking statements, whether as a result of new information, future\nevents, or otherwise, except as expressly required by law. Forward-looking\nstatements speak only as of the date they are made and should not be relied\nupon as representing Cycurion’s plans and expectations as of any subsequent\ndate.\n\nCycurion Investor Relations: \n(888) 341-6680 \ninvestors@cycurion.com \n\nCycurion Media Relations: \n(888) 341-6680 \nmedia@cycurion.com\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-09-03T12:30:01.270205426Z","server_sent_at_ms":1788438601270},"received_at":"2026-09-03T12:30:01.333Z","source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355918/0/en/cycurion-announces-approximately-800-000-in-annual-contract-spend-accelerating-commercial-expansion.html"},"analysis":{"id":"124049","press_release_id":"135167","analysis_json":{"industry":{"label":"IT Services","sector":"Information Technology"},"redFlags":["Aggregate ~$800K annual spend is spread across multiple engagements with no individual contract values, durations, or revenue timing disclosed","Highly promotional framing ('Why It Matters') around a relatively small award total; forward-looking-spend, not booked revenue"],"eventType":"operations_update","narrative":"Cycurion announced several new engagements totaling approximately $800,000 in annual contract spend, its first public disclosure of the awards.\n\nThe work includes a pharmaceutical-industry engagement supporting an AI Center of Excellence and a new award from NACCHO, where Cycurion already serves as a Diamond Affiliate Partner.\n\nCEO L. Kevin Kelly framed the wins as evidence that the company's commercial healthcare and life-sciences expansion is converting stated strategy into paying accounts, with scope spanning cybersecurity, business continuity, program management, and AI delivery.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"First commercial life-sciences win for a micro-cap cybersecurity name -- watch whether the pharma AI Center of Excellence and NACCHO accounts expand into material backlog."},"keyFigures":{"customDimensions":{"annual_contract_spend":800000}},"quotedText":"We are not dabbling in commercial. We are building it.","namedEntities":{"people":[{"name":"L. Kevin Kelly","role":"Chairman and Chief Executive Officer of Cycurion"}],"products":["ARx platform","AI Center of Excellence"],"companies":[{"name":"Cycurion, Inc.","ticker":"CYCU","relationship":"filer"},{"name":"National Association of County and City Health Officials (NACCHO)","relationship":"customer"},{"name":"Axxum Technologies LLC","relationship":"subsidiary"},{"name":"Cloudburst Security LLC","relationship":"subsidiary"},{"name":"Cycurion Innovation, Inc.","relationship":"subsidiary"}],"dollarAmounts":[{"amount":"$800,000","context":"approximate aggregate annual contract spend across the newly announced engagements"}]},"materialImpact":{"score":2,"reasoning":"New commercial and public-health contract wins totaling only ~$800,000 in aggregate annual spend; positive for the commercial-expansion narrative but too small and under-specified (no durations, no per-contract values) to be market-moving for the filer."},"tickerRelevance":{"others":[],"primary":"CYCU"},"globalImportance":14,"audienceRelevance":12,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"small contract-win announcement (~$800K annual spend)","issuerAuthored":true,"promotionalTone":"high","householdBrandBoost":0,"retailFavoriteBoost":0}},"event_type":"operations_update","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Cycurion announced several new engagements totaling approximately $800,000 in annual contract spend, its first public disclosure of the awards.\n\nThe work includes a pharmaceutical-industry engagement supporting an AI Center of Excellence and a new award from NACCHO, where Cycurion already serves as a Diamond Affiliate Partner.\n\nCEO L. Kevin Kelly framed the wins as evidence that the company's commercial healthcare and life-sciences expansion is converting stated strategy into paying accounts, with scope spanning cybersecurity, business continuity, program management, and AI delivery.","key_figures":{"customDimensions":{"annual_contract_spend":800000}},"named_entities":{"people":[{"name":"L. Kevin Kelly","role":"Chairman and Chief Executive Officer of Cycurion"}],"products":["ARx platform","AI Center of Excellence"],"companies":[{"name":"Cycurion, Inc.","ticker":"CYCU","relationship":"filer"},{"name":"National Association of County and City Health Officials (NACCHO)","relationship":"customer"},{"name":"Axxum Technologies LLC","relationship":"subsidiary"},{"name":"Cloudburst Security LLC","relationship":"subsidiary"},{"name":"Cycurion Innovation, Inc.","relationship":"subsidiary"}],"dollarAmounts":[{"amount":"$800,000","context":"approximate aggregate annual contract spend across the newly announced engagements"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-03T13:24:28.914Z","global_importance":14,"audience_relevance":12,"importance_components":{"tickerTier":"micro-cap","eventGravity":"small contract-win announcement (~$800K annual spend)","issuerAuthored":true,"promotionalTone":"high","householdBrandBoost":0,"retailFavoriteBoost":0}},"durationMs":74546,"modelName":"glm-4.7"}}